(Q51372555)

4 April 2018

title

Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. (English)

1 reference

4 April 2018

1 reference

Altan Onat

1

1 reference

4 April 2018

Günay Can

2

1 reference

4 April 2018

Ender Örnek

3

1 reference

4 April 2018

Gökhan Çiçek

4

1 reference

4 April 2018

Erkan Ayhan

5

1 reference

4 April 2018

Yüksel Doğan

6

1 reference

4 April 2018

publication date

2 June 2011

1 reference

4 April 2018

published in

Obesity

1 reference

4 April 2018

volume

20

1 reference

4 April 2018

issue

4

1 reference

4 April 2018

page(s)

842-848

1 reference

4 April 2018

Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Oxidative stress is associated with adiposity and insulin resistance in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulin-sensitive Pima Indians by differential display PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Serum gamma glutamyltransferase as a marker of metabolic syndrome and coronary disease likelihood in nondiabetic middle-aged and elderly adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Plasma bilirubin and gamma-glutamyltransferase activity are inversely related in dyslipidemic patients with metabolic syndrome: relevance to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels--a prospective and cross-sectional evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Risk factors and cardiovascular disease in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Lowering the criterion for impaired fasting glucose is in order

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

"Atherogenic index of plasma" (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Prospective Study of Serum -Glutamyltransferase and Risk of NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

The relationship between serum gamma-glutamyl transpeptidase levels and hypertension: common in drinkers and nondrinkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

Gamma-glutamyltransferase and diabetes--a 4 year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

inferred from DOI database lookup

7 January 2021

based on heuristic

Follow-up report on the diagnosis of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.136

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/OBY.2011.136

1 reference

4 April 2018

1 reference

4 April 2018